A business in context

JNJ research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-09-27 · 0000200406-26-000197

  2. 8-K · Current report

    Report date 2026-10-13 · 0000200406-26-000189 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-09-08 · 0000200406-26-000185

  4. 4 · Ownership change

    Report date 2026-09-08 · 0000200406-26-000184

  5. 4 · Ownership change

    Report date 2026-09-08 · 0000200406-26-000183

  6. 4 · Ownership change

    Report date 2026-09-02 · 0000200406-26-000179

  7. 4 · Ownership change

    Report date 2026-08-17 · 0000200406-26-000175

  8. 4 · Ownership change

    Report date 2026-08-13 · 0000200406-26-000173

  9. 4 · Ownership change

    Report date 2026-08-05 · 0000200406-26-000171

  10. 4 · Ownership change

    Report date 2026-08-06 · 0000200406-26-000169

  11. 8-K · Current report

    Report date 2026-08-04 · 0000200406-26-000167 · Items 5.02,9.01

  12. 8-K · Current report

    Report date 2026-07-29 · 0000200406-26-000163 · Items 7.01,9.01

  13. 8-K · Current report

    Report date 2026-07-27 · 0000200406-26-000155 · Items 7.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-06-28 · 0000200406-26-000153

  15. 8-K · Current report

    Report date 2026-07-15 · 0000200406-26-000146 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-04-23 · 0000200406-26-000089 · Items 5.07,9.01

  17. 10-Q · Quarterly report

    Report date 2026-03-29 · 0000200406-26-000087

  18. 8-K · Current report

    Report date 2026-04-14 · 0000200406-26-000076 · Items 2.02,8.01,9.01

  19. DEF 14A · Proxy statement

    Report date 2026-03-11 · 0000200406-26-000063

  20. 10-K · Annual report

    Report date 2025-12-28 · 0000200406-26-000016

  21. 8-K · Current report

    Report date 2026-01-21 · 0000200406-26-000002 · Items 2.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-28 · 0000200406-25-000209

  23. 8-K · Current report

    Report date 2025-10-14 · 0000200406-25-000201 · Items 2.02,8.01,9.01

  24. 8-K · Current report

    Report date 2025-09-08 · 0000200406-25-000190 · Items 5.02

  25. 10-Q · Quarterly report

    Report date 2025-06-29 · 0000200406-25-000178

  26. 8-K · Current report

    Report date 2025-07-16 · 0000200406-25-000170 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-06-10 · 0000200406-25-000152 · Items 5.02

  28. 8-K · Current report

    Report date 2025-04-24 · 0000200406-25-000141 · Items 5.02,5.07,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-30 · 0000200406-25-000119

  30. 8-K · Current report

    Report date 2025-04-15 · 0000200406-25-000110 · Items 2.02,8.01,9.01

  31. 8-K · Current report

    Report date 2025-03-31 · 0000200406-25-000106 · Items 7.01,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-03-12 · 0000200406-25-000099

  33. 8-K · Current report

    Report date 2025-02-26 · 0001193125-25-036773 · Items 8.01,9.01

  34. 8-K · Current report

    Report date 2025-02-20 · 0001193125-25-030851 · Items 8.01,9.01

  35. 10-K · Annual report

    Report date 2024-12-29 · 0000200406-25-000038

  36. 8-K/A · Current report

    Report date 2025-01-22 · 0000200406-25-000007 · Items 9.01

  37. 8-K · Current report

    Report date 2025-01-22 · 0000200406-25-000003 · Items 2.02,9.01

  38. SC 13G/A · Ownership disclosure

    0000904454-24-000574

  39. 10-Q · Quarterly report

    Report date 2024-09-29 · 0000200406-24-000096

  40. SC 13G · Ownership disclosure

    0000904454-24-000538

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 10 transaction rows10SGrant / award: 3 transaction rows3AExercise / conversion: 14 transaction rows14MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

27 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-10
Pinto Daniel EA · Grant / award
Acquired
Deferred Share Units
Derivative security
113.1276.31
2026-09-08
2026-09-10
Woods Eugene A.A · Grant / award
Acquired
Deferred Share Units
Derivative security
135.72276.31
2026-09-08
2026-09-10
HEWSON MARILLYN AA · Grant / award
Acquired
Deferred Share Units
Derivative security
180.96276.31
2026-09-02
2026-09-04
Schmid TimothyS · Sale
Disposed
Common Stock22527.0274.74
2026-09-02
2026-09-04
Schmid TimothyS · Sale
Disposed
Common Stock11070.0274.74
2026-09-02
2026-09-04
Schmid TimothyM · Exercise / conversion
Acquired
Common Stock11070.0131.94
2026-09-02
2026-09-04
Schmid TimothyM · Exercise / conversion
Acquired
Common Stock22527.0151.41
2026-09-02
2026-09-04
Schmid TimothyM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
11070.00.0
2026-09-02
2026-09-04
Schmid TimothyM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
22527.00.0
2026-08-17
2026-08-18
Taubert Jennifer LS · Sale
Disposed
Common Stock15000.0263.36
2026-08-17
2026-08-18
Taubert Jennifer LM · Exercise / conversion
Acquired
Common Stock15000.0115.67
2026-08-17
2026-08-18
Taubert Jennifer LM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
15000.00.0
2026-08-13
2026-08-14
Duato JoaquinS · Sale
Disposed
Common Stock20976.0262.0
2026-08-13
2026-08-14
Duato JoaquinM · Exercise / conversion
Acquired
Common Stock123291.0115.67
2026-08-13
2026-08-14
Duato JoaquinS · Sale
Disposed
Common Stock102315.0261.0
2026-08-13
2026-08-14
Duato JoaquinM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
123291.00.0
2026-08-06
2026-08-07
Forminard ElizabethS · Sale
Disposed
Common Stock6574.0255.93
2026-08-06
2026-08-07
Forminard ElizabethM · Exercise / conversion
Acquired
Common Stock9344.0131.94
2026-08-06
2026-08-07
Forminard ElizabethS · Sale
Disposed
Common Stock9344.0257.76
2026-08-06
2026-08-07
Forminard ElizabethM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
9344.00.0
2026-08-05
2026-08-07
Duato JoaquinS · Sale
Disposed
Common Stock41957.0258.06
2026-08-05
2026-08-07
Duato JoaquinS · Sale
Disposed
Common Stock6523.0258.74
2026-07-20
2026-07-21
Broadhurst VanessaM · Exercise / conversion
Acquired
Common Stock11129.0129.51
2026-07-20
2026-07-21
Broadhurst VanessaM · Exercise / conversion
Acquired
Common Stock11925.0131.94
2026-07-20
2026-07-21
Broadhurst VanessaS · Sale
Disposed
Common Stock23054.0251.27
2026-07-20
2026-07-21
Broadhurst VanessaM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
11129.00.0
2026-07-20
2026-07-21
Broadhurst VanessaM · Exercise / conversion
Disposed
Employee Stock Options (Right to Buy)
Derivative security
11925.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000200406JOHNSON & JOHNSON
DePuyJohnson & Johnson Pharmaceutical Research and DevelopmentJanssen BiotechAlzaCilag AGTibotecJohnson & Johnson Consumer CompaniesJohnson & Johnson Health Care SystemsJohnson & Johnson Innovation - JJDC, Inc.Johnson & Johnson Vision CareLifeScanJohnson & Johnson (United Kingdom)Johnson & Johnson (Ireland)Johnson & Johnson (Sweden)Johnson & Johnson (France)

Showing 15 of 15 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300G0CFPGEF6X2043
GLEIF legal name
Johnson & Johnson
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-07-15T13:22:28Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • J&J · alias · wikidata
  • Johnson and Johnson · alias · wikidata
  • DePuy · subsidiary · wikidata
  • DePuy, A Johnson & Johnson Company · subsidiary · wikidata
  • DePuy Manufacturing · subsidiary · wikidata
  • DePuySynthes, A Johnson & Johnson Company · subsidiary · wikidata
  • DePuy Synthes Companies of Johnson & Johnson · subsidiary · wikidata
  • DePuy Synthes · subsidiary · wikidata
  • Johnson & Johnson Pharmaceutical Research and Development · subsidiary · wikidata
  • Janssen Research & Development · subsidiary · wikidata
  • Johnson & Johnson Pharmaceutical Research & Development · subsidiary · wikidata
  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · subsidiary · wikidata
  • Janssen Biotech · subsidiary · wikidata
  • Centocor · subsidiary · wikidata
  • Centocor Biotech · subsidiary · wikidata
  • Centocor Ortho Biotech, Inc. · subsidiary · wikidata
  • Alza · subsidiary · wikidata
  • ALZA Corporation · subsidiary · wikidata
  • Cilag AG · subsidiary · wikidata
  • Cilag · subsidiary · wikidata
  • Tibotec · subsidiary · wikidata
  • Johnson & Johnson Consumer Companies · subsidiary · wikidata
  • Johnson & Johnson, Group of Consumer Companies · subsidiary · wikidata
  • Johnson & Johnson Health Care Systems · subsidiary · wikidata
  • Johnson & Johnson Innovation - JJDC, Inc. · subsidiary · wikidata
  • Johnson & Johnson Innovation · subsidiary · wikidata
  • Johnson & Johnson Vision Care · subsidiary · wikidata
  • LifeScan · subsidiary · wikidata
  • Johnson & Johnson (United Kingdom) · subsidiary · wikidata
  • Johnson & Johnson (Ireland) · subsidiary · wikidata
  • Johnson & Johnson (Sweden) · subsidiary · wikidata
  • Johnson & Johnson (France) · subsidiary · wikidata
  • JOHNSON & JOHNSON ET AL · former SEC name · 1995-10-06 to 1996-01-23
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-29$88.82B$95.41B
2023-12-31$85.16B$94.16B
2023-01-01$79.99B$92.05B
2022-01-02$78.74B$97.85B
2021-01-03$82.58B$107.51B
2019-12-29$82.06B$108.15B
2018-12-30$81.58B$109.46B
2017-12-31$76.45B$105.08B

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗